
TVRD P/E Ratio
P/E Ratio as of Jul 2, 2025: -0.72
Average-0.8636
Median-0.8600
Minimum-1.00
Maximum-0.7200
-0.72
Past Month+0.24 (25.00%)
The P/E ratio for TVRD is -0.72 as of Jul 2, 2025. This represents a increase of 89.47% compared to its 12-month average P/E ratio of -0.38. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Cara Therapeutics Inc P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Cara Therapeutics Inc’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Cara Therapeutics Inc to industry peers.
Cara Therapeutics Inc P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Cara Therapeutics Inc’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Cara Therapeutics Inc to industry peers.
TVRD P/E Ratio Insights
See Cara Therapeutics Inc’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in TVRD
Order type
Buy in
Order amount
Est. shares
0 shares
TVRD P/E Ratio Historic Data
Date | Stock price | P/E ratio |
---|---|---|
Jul 1, 2025 | $22.15 | -0.75 |
Jun 2, 2025 | $29.755 | -1.00 |
May 1, 2025 | $25.45 | -0.55 |
Apr 1, 2025 | $14.82 | -0.50 |
Mar 3, 2025 | $13.89 | -0.30 |
Feb 3, 2025 | $14.34 | -0.31 |
Jan 2, 2025 | $16.08 | -0.34 |
TVRD End of Year P/E Ratio
Date | P/E ratio | Change |
---|---|---|
2025 | -0.72 | +84.62% |
2024 | -0.39 | +14.71% |
2023 | -0.34 | -94.74% |
2022 | -6.47 | -7.83% |
2021 | -7.02 | -103.75% |
2020 | 186.98 | — |
FAQs About Cara Therapeutics Inc (TVRD) P/E ratio
The latest P/E ratio of TVRD is -0.72, as of Jul 2, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Cara Therapeutics Inc’s last 12-month average P/E ratio is -0.38, compared to its current P/E ratio of -0.72. This reflects a increase of 89.47%.
Cara Therapeutics Inc’s current P/E ratio of -0.72 is higher than its last 12-month average P/E of -0.38. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Cara Therapeutics Inc’s average P/E ratio over the last 3 years is -2.08. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Cara Therapeutics Inc’s average P/E ratio over the last 5 years is 17.94. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.